Continues to Strengthen Its Pandemic Preparedness and Biodefense Vaccine Portfolio ATLANTA, GA - April 9, 2025 (NEWMEDIAWIRE) ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Serosurveys have expanded our understanding of infectious diseases in Africa, revealing the true burden of pathogens beyond ...

Health News Live: Tanzania has officially declared the end of the Marburg virus outbreak, one of the deadliest hemorrhagic fever disease, which is similar to Ebola. The outbreak, which officially ...

Imagine a virus so lethal that up to 90% of those infected don’t survive. That’s Marburg—a rare but extremely dangerous disease with no known cure. In this video, we explore its history ...

Pharmaceutical maker Gilead is currently advancing Obeldesivir to Phase 2 clinical trials for Marburg virus, a close relative of Ebola, Science Alert reported.

Pharmaceutical maker Gilead is currently advancing Obeldesivir to Phase 2 clinical trials for Marburg virus, a close relative of Ebola. Geisbert also emphasized the importance of funding from the ...

The deadly Marburg virus outbreak, similar to Ebola, is seriously concerning the WHO (World Health Organization). In Belgium, ...

Marburg virus disease is highly virulent and causes haemorrhagic fever. It belongs to the same family as the virus that causes Ebola virus disease. Illness caused by Marburg virus begins abruptly.

WHO Chief Dr. Tedros warns that another pandemic is inevitable, urging global preparedness. He stresses the urgency of ...